CD47 and neoplasm: A siRNA targeting CD47 on tumor cells was systematically delivered by HA-coated lipid NPs into melanoma cancer cells, resulting in CD47 knockdown, which facilitated phagocytosis and led to the inhibition of melanoma growth and metastasis [93].